Niro Okimoto

1.8k total citations
119 papers, 1.2k citations indexed

About

Niro Okimoto is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Niro Okimoto has authored 119 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 29 papers in Pulmonary and Respiratory Medicine and 28 papers in Infectious Diseases. Recurrent topics in Niro Okimoto's work include Pneumonia and Respiratory Infections (40 papers), Tuberculosis Research and Epidemiology (18 papers) and Mycobacterium research and diagnosis (14 papers). Niro Okimoto is often cited by papers focused on Pneumonia and Respiratory Infections (40 papers), Tuberculosis Research and Epidemiology (18 papers) and Mycobacterium research and diagnosis (14 papers). Niro Okimoto collaborates with scholars based in Japan, United Kingdom and United States. Niro Okimoto's co-authors include Kazunobu Ouchi, Naoyuki Miyashita, Hiroto Akaike, Yoshihiro Kobashi, Toshiharu Matsushima, Yasuhiro Kawai, Naoyuki Miyashita, Hideto Teranishi, Rinzō Soejima and Toshikiyo Hayashi and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.

In The Last Decade

Niro Okimoto

113 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niro Okimoto Japan 20 788 365 267 243 234 119 1.2k
J. W. van’t Wout Netherlands 17 746 0.9× 483 1.3× 117 0.4× 78 0.3× 125 0.5× 34 1.1k
Smita Kothari United States 18 691 0.9× 255 0.7× 162 0.6× 85 0.3× 340 1.5× 49 1.1k
Ki Wook Yun South Korea 20 679 0.9× 284 0.8× 131 0.5× 249 1.0× 166 0.7× 91 1.2k
Beatriz Rosón Spain 21 1.2k 1.5× 331 0.9× 296 1.1× 105 0.4× 157 0.7× 47 2.2k
Jong‐Min Chen Taiwan 19 660 0.8× 297 0.8× 102 0.4× 207 0.9× 111 0.5× 45 1.0k
J.P. Thys Belgium 22 523 0.7× 307 0.8× 295 1.1× 92 0.4× 295 1.3× 62 1.3k
G. Ruckdeschel Germany 16 402 0.5× 228 0.6× 254 1.0× 113 0.5× 267 1.1× 35 1.4k
Kristoffer Strålin Sweden 26 1.1k 1.4× 397 1.1× 144 0.5× 228 0.9× 73 0.3× 73 1.6k
Yoshihiro Kobashi Japan 25 1.7k 2.1× 1.2k 3.4× 375 1.4× 172 0.7× 675 2.9× 159 2.2k
Ingegerd Kallings Sweden 17 733 0.9× 117 0.3× 110 0.4× 353 1.5× 133 0.6× 47 1.1k

Countries citing papers authored by Niro Okimoto

Since Specialization
Citations

This map shows the geographic impact of Niro Okimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niro Okimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niro Okimoto more than expected).

Fields of papers citing papers by Niro Okimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niro Okimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niro Okimoto. The network helps show where Niro Okimoto may publish in the future.

Co-authorship network of co-authors of Niro Okimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Niro Okimoto. A scholar is included among the top collaborators of Niro Okimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niro Okimoto. Niro Okimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwamoto, Yuichiro, Takatoshi Anno, Kazutaka Nakashima, et al.. (2020). Primary Squamous Cell Carcinoma of the Thyroid with Severe Tracheal Invasion: A Case Report. European Thyroid Journal. 10(6). 548–550. 3 indexed citations
2.
Anno, Takatoshi, et al.. (2018). A rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus: a case report. Journal of Medical Case Reports. 12(1). 286–286. 4 indexed citations
3.
Horio, T., Maki Akiyama, Yoshio Iwashima, et al.. (2016). Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis. Journal of Human Hypertension. 31(7). 450–456. 3 indexed citations
4.
Kato, Tadashi, Naoyuki Miyashita, Yasuhiro Kawai, et al.. (2016). Changes in physical function after hospitalization in patients with nursing and healthcare-associated pneumonia. Journal of Infection and Chemotherapy. 22(10). 662–666. 18 indexed citations
5.
Miyashita, Naoyuki, Yasuhiro Kawai, Takaaki Tanaka, et al.. (2015). Antibody responses of Chlamydophila pneumoniae pneumonia: Why is the diagnosis of C. pneumoniae pneumonia difficult?. Journal of Infection and Chemotherapy. 21(7). 497–501. 11 indexed citations
6.
Okimoto, Niro, et al.. (2014). Association between ImmunoCard Mycoplasma test and particle agglutination (PA) method in Mycoplasma pneumonia diagnosis. 40(2). 61–63. 1 indexed citations
7.
Okimoto, Niro, et al.. (2013). Clinical effect of 3g/day administration of meropenem on severe pneumonia. 39(1). 43–47. 2 indexed citations
8.
Miyashita, Naoyuki, Yasuhiro Kawai, Hiroto Akaike, et al.. (2012). Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infectious Diseases. 12(1). 46 indexed citations
9.
Miyashita, Naoyuki, Tadashi Kato, Toshikiyo Hayashi, et al.. (2012). Chlamydophila pneumoniae serology: cross-reaction with Mycoplasma pneumoniae infection. Journal of Infection and Chemotherapy. 19(2). 256–260. 12 indexed citations
10.
Okimoto, Niro, et al.. (2011). Clinical features of Moraxella catarrhalis respiratory infections. 37(1). 57–62. 1 indexed citations
11.
Yoshida, Koichiro, Yoshihito Niki, Niro Okimoto, et al.. (2011). Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis. Journal of Infection and Chemotherapy. 17(5). 678–685. 8 indexed citations
12.
Okimoto, Niro, et al.. (2010). Clinical features of Escherichia coli pneumonia. Journal of Infection and Chemotherapy. 16(3). 216–218. 10 indexed citations
13.
Kobashi, Yoshihiro, Keiji Mouri, Naoyuki Miyashita, et al.. (2009). QuantiFERON TB-2G test for patients with active tuberculosis stratified by age groups. Scandinavian Journal of Infectious Diseases. 41(11-12). 841–846. 24 indexed citations
14.
Nakano, Eduardo Yoshio, et al.. (2001). A Pertussis Outbreak in a Ward for Severely Retarded. Kansenshogaku zasshi. 75(11). 916–922. 1 indexed citations
15.
Kobashi, Yoshihiro, et al.. (2001). Clinical Analysis of Community-Acquired Pneumonia and Pulmonary Tuberculosis in the Elderly and Advances in Treatment.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 38(3). 312–316. 1 indexed citations
16.
Kobashi, Yoshihiro, et al.. (2000). Clinical Analysis of Community-Acquired Pneumonia Requiring Hospitalization in a Cummunity Hospital. Kansenshogaku zasshi. 74(1). 43–50. 3 indexed citations
17.
Kobashi, Yoshihiro, Kazue Fujita, Junichi Nakamura, et al.. (1999). An Analysis of Unresectable Non-small Cell Lung Cancer (Clinical Stage III-IV Disease) Cases Surviving More Than 3 Years.. Haigan. 39(3). 275–281.
18.
Niki, Y, Niro Okimoto, Hiroshi Kishimoto, et al.. (1996). Clinical study on sparfloxacin in the treatment of chlamydial respiratory infections. 44(3). 148–157. 2 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. W. van’t Wout Breakdown of academic impact, for papers by Smita Kothari Breakdown of academic impact, for papers by Ki Wook Yun Breakdown of academic impact, for papers by Beatriz Rosón Breakdown of academic impact, for papers by Jong‐Min Chen Breakdown of academic impact, for papers by J.P. Thys Breakdown of academic impact, for papers by G. Ruckdeschel Breakdown of academic impact, for papers by Kristoffer Strålin Breakdown of academic impact, for papers by Yoshihiro Kobashi Breakdown of academic impact, for papers by Ingegerd Kallings
Rankless by CCL
2026